ACLARIS THERAPEUTICS INC

Ticker: ACRS CUSIP: 00461U105 Class: COM

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,434,164 Value ($000) $4,317 Avg Close $2.53 Range $1.74 - $3.48
Q3 2025
Shares 1,067,656 Value ($000) $2,029 Avg Close $1.74 Range $1.38 - $2.15
Q2 2025
Shares 797,134 Value ($000) $1,132 Avg Close $1.35 Range $1.05 - $1.66
Q1 2025
Shares 865,011 Value ($000) $1,323 Avg Close $2.13 Range $1.47 - $2.79
Q4 2024
Shares 908,819 Value ($000) $2,254 Avg Close $2.49 Range $1.12 - $5.17
Q3 2024
Shares 332,406 Value ($000) $382 Avg Close $1.23 Range $1.10 - $1.43
Q2 2024
Shares 115,580 Value ($000) $127 Avg Close $1.17 Range $0.95 - $1.40
Q1 2024
Shares 100,773 Value ($000) $125 Avg Close $1.19 Range $0.86 - $1.51
Q3 2023
Shares 201,233 Value ($000) $1,378 Avg Close $8.55 Range $6.24 - $11.12
Q2 2023
Shares 210,837 Value ($000) $2,186 Avg Close $9.05 Range $7.87 - $10.91
Q1 2023
Shares 176,650 Value ($000) $1,429 Avg Close $12.69 Range $5.77 - $18.54
Q4 2022
Shares 16,846 Value ($000) $265 Avg Close $16.09 Range $14.02 - $18.96
Q3 2022
Shares 26,854 Value ($000) $423 Avg Close $15.75 Range $12.82 - $18.59
Q3 2020
Shares 31,575 Value ($000) $81 Avg Close $2.24 Range $1.48 - $3.34